Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer
While biologics have been successfully applied in TNF antagonist treatments, there are no clinically approved small molecules that target TNF. Here, the authors discover potent small molecule inhibitors of TNF, elucidate their molecular mechanism, and demonstrate TNF inhibition in vitro and in vivo.
Guardado en:
Autores principales: | James O’Connell, John Porter, Boris Kroeplien, Tim Norman, Stephen Rapecki, Rachel Davis, David McMillan, Tracy Arakaki, Alex Burgin, David Fox III, Tom Ceska, Fabien Lecomte, Alison Maloney, Alex Vugler, Bruce Carrington, Benjamin P Cossins, Tim Bourne, Alastair Lawson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cd8aea08c83948d3a69fc5302494dedc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural insights into the disruption of TNF-TNFR1 signalling by small molecules stabilising a distorted TNF
por: David McMillan, et al.
Publicado: (2021) -
A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF
por: Daniel J. Lightwood, et al.
Publicado: (2021) -
Temperature effects on carbon storage are controlled by soil stabilisation capacities
por: Iain P. Hartley, et al.
Publicado: (2021) -
Silk micrococoons for protein stabilisation and molecular encapsulation
por: Ulyana Shimanovich, et al.
Publicado: (2017) -
The architecture and stabilisation of flagellotropic tailed bacteriophages
por: Joshua M. Hardy, et al.
Publicado: (2020)